FDA Approval Activities for this Drug
Equagesic (meprobamate with aspirin) Tablets, Women First HealthCare NDA 11-702/S-036 ASPIRIN; MEPROBAMATE Tablet; 325MG;200MG EQUAGESIC WOMEN FIRST 014547 MEPROBAMATE Tablet; 200MG MEPROBAMATE Eon 014547 MEPROBAMATE Tablet; 400MG MEPROBAMATE Eon 080655 MEPROBAMATE Tablet; 400MG MEPROBAMATE Geneva 009698 MEPROBAMATE Tablet; 200MG MILTOWN MEDPOINTE HLC
009698 MEPROBAMATE Tablet; 400MG MILTOWN MEDPOINTE HLC
083618 MEPROBAMATE Tablet; 400MG MEPROBAMATE Mylan
084332 MEPROBAMATE Tablet; 600MG MEPROBAMATE Roxane
083343 MEPROBAMATE Tablet; 400MG MEPROBAMATE SCHERER 016249 MEPROBAMATE Tablet; 400MG TRANMEP SOLVAY
083494 MEPROBAMATE Tablet; 400MG MEPROBAMATE TABLICAPS
083304 MEPROBAMATE Tablet; 200MG MEPROBAMATE Watson 085720 MEPROBAMATE Tablet; 200MG MEPROBAMATE Watson 085721 MEPROBAMATE Tablet; 400MG MEPROBAMATE Watson 083308 MEPROBAMATE Tablet; 400MG MEPROBAMATE Watson 015417 MEPROBAMATE Tablet; 200MG MEPROBAMATE West Ward
015417 MEPROBAMATE Tablet; 400MG MEPROBAMATE West Ward |Equagesic (meprobamate) Tablets, Leitner Pharma, Manufacturing Change or Addition | Meprobamate Tablets, InvaGen Pharma, Approval